08/01/2007

Pre-surgery chemo for breast cancer?

By Lauran Neergaard
The Associated Press

More breast cancer patients are being offered chemotherapy before surgery instead of afterward — amid much debate about how to do it right and when it's a good option.

Doctors have long known that having chemo first sometimes shrinks an advanced tumor enough that a woman can undergo smaller surgery and keep her breast.

What's new is the hope that it may help more women with earlier-stage cancer in a different way: by letting doctors switch drugs if the tumor doesn't respond right away. Wait until after surgery, and there's no way to measure the drugs' effect.

Does it really work? There's the rub: Studies show it doesn't endanger a woman to have chemo before surgery — but so far, the hoped-for better survival hasn't been proven either.

That conundrum means whether a woman is offered pre-surgery chemo, and how, depends more on what doctor she chooses than on firm guidelines.

"I'm a fan of letting patients know what their choices are,” says Dr. Minetta Liu of Georgetown University Hospital, a proponent who estimates that up to 10 percent of her patients who need chemo choose it pre-surgery. "You're not asking them to do something that's going to have a negative impact on their survival. It just may not help.”

On the other side is Dr. Clifford Hudis of Memorial Sloan-Kettering Cancer Center, who wants more research to settle the issue before the fledgling trend becomes routine.

"It should not be used ... just because it exists,” Hudis says.

With breast cancer deaths dropping since 1990, "the notion that we should move to a different strategy should be challenged, he adds. "We have uncharted territory.”

More than 178,000 U.S. women will be diagnosed with breast cancer this year. Thanks to improvements in treatment and early detection, many will survive long-term. Still, breast cancer kills 40,000 a year.

Not every patient needs chemotherapy. It depends on the tumor's size and type, and whether the cancer has begun to spread.

There are no good statistics on how often women who need chemo choose it upfront. Most still have chemo after surgery, especially those treated in community hospitals.

But with more specialized cancer centers pushing upfront chemo for earlier-stage patients — and dozens of clinical trials testing different methods — the National Cancer Institute brought together experts last spring to debate the evidence behind what all agreed is a rising trend.

What's clear: If shrinking a tumor might save a woman's breast, or offer a markedly smaller lumpectomy, then pre-surgery chemo is a good option.

Lauran Neergaard covers health and medical issues for The Associated Press in Washington.